CellSource Secures Tokyo Egg Freezing Program Contract
Company Announcements

CellSource Secures Tokyo Egg Freezing Program Contract

CellSource Co., Ltd. (JP:4880) has released an update.

CellSource Co., Ltd. has secured a contract with the Tokyo Metropolitan Government to conduct online information sessions for a program subsidizing egg freezing procedures. By offering these sessions, CellSource ensures candidates are well-informed about the process, utilizing their expertise from the ‘Egg Freezing Anshin Bank’ storage service. The company specializes in regenerative medicine and has a distinguished history of over 93,000 cell-related procedures.

For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App